ZoBio was founded in 2004 as a spin-off of Leiden University, The Netherlands. ZoBio is self funded and offers primarily research services on a fee-for-service basis to customers across the pharmaceutical and biotechnology industries. Customers include 7 of the top 15 largest pharma and various mid-size pharmaceutical companies. The main activities center around the development and commercialization of biophysical technologies that enable new approaches to drug development.